Clenbuterol 40 Pharmaqo

£43.00

Clenbuterol 40 Pharmaqo is a selective beta-2 adrenergic receptor agonist research chemical designed for in-vitro metabolic pathway investigations and cardiovascular studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Clenbuterol 40 Pharmaqo
Clenbuterol 40 Pharmaqo
£43.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications and Compound Profile

Clenbuterol 40 Pharmaqo is a selective beta-2 adrenergic receptor agonist extensively utilised in metabolic research applications. This bronchodilator compound demonstrates potent thermogenic properties in laboratory studies, making it valuable for investigating cellular energy expenditure pathways and adrenergic signalling mechanisms. Research teams Stroid UK Shop examine this compound’s effects on lipolysis, protein synthesis modulation, and cardiovascular parameters in controlled experimental settings. The pharmaceutical-grade formulation ensures consistent results across research protocols examining beta-adrenergic receptor pharmacology.

Experimental Research Applications

Laboratory investigations utilise clenbuterol to study thermogenesis regulation and metabolic rate enhancement mechanisms. Researchers analyse its interaction with adenylyl cyclase pathways and cyclic adenosine monophosphate (cAMP) elevation in cellular models. Studies examine the compound’s selectivity for beta-2 receptors versus beta-1 subtypes, providing insights into tissue-specific adrenergic responses. The compound serves as a valuable tool for investigating brown adipose tissue activation and understanding sympathomimetic effects in cardiovascular research. Scientists studying metabolic modulators frequently incorporate this agent into comparative analyses with other thermogenic compounds.

Technical Specifications and Storage

Clenbuterol 40 Pharmaqo Research Specifications
Active Compound Clenbuterol Hydrochloride
Concentration 40 mcg per tablet
CAS Number 21898-19-1
Molecular Formula C₁₂H₁₈Cl₂N₂O
Molecular Weight 277.19 g/mol
Storage Conditions Room temperature, dry environment
Manufacturer Pharmaqo Laboratories

Research facilities studying advanced metabolic pathways often combine investigations with selective androgen receptor modulators or peptide compounds to examine comprehensive endocrine system interactions. The compound’s well-characterised pharmacokinetic profile makes it suitable for time-course studies and dose-response analyses in laboratory settings.

Research Use Compliance

This product is intended strictly for in-vitro research and laboratory analysis purposes only. Not approved for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must ensure appropriate safety protocols and regulatory compliance when handling this compound in laboratory environments.

Related